Clinical Trial for Patients in the United States and Canada
Vertex Spring Trial

About the SPRING Trial

Studying VX-210, an investigational therapy for acute traumatic cervical spinal cord injury requiring surgery

The purpose of the SPRING Trial is to determine the efficacy and safety of an investigational therapy, VX-210, in subjects with acute traumatic cervical spinal cord injury.

VX-210 is applied to the spinal cord during initial decompression/stabilization surgery.

The VX-210 Clinical Trial will enroll about 150 patients at multiple clinical trial sites in the United States and Canada. For a list of sites enrolling, please visit ClinicalTrials.gov.

Read more about key participation requirements for the SPRING Trial

Why participate in a clinical trial?

Clinical trials are research studies to evaluate new treatments. Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.

This website contains information related to general medical conditions and is provided for educational purposes only. It is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

The study described here investigates treatments or outcomes that have not received regulatory approval from a health authority. The information presented here is not meant to convey conclusions of safety or effectiveness. There is no guarantee that the outcome of this trial will result in approval by a regulatory authority. The information about the SPRING Trial used in this website comes from ClinicalTrials.gov.